To determine whether our therapeutic strategy in the T2D mouse model is relevant to humans, we studied the effect of Gastrin‐SiO2 microspheres in HIECs from healthy donors and T2D patients. This evidence concerns the gene GAST and type 2 diabetes mellitus.